William Blair downgraded InnovAge from Outperform to Mkt Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 5/16/2022 | $6.00 → $5.00 | Outperform → Neutral | Robert W. Baird |
| 4/20/2022 | $4.00 → $5.00 | Neutral → Underweight | Piper Sandler |
| 1/10/2022 | $8.00 → $5.00 | Neutral | Citigroup |
| 12/28/2021 | $15.00 → $4.00 | Buy → Neutral | Goldman Sachs |
| 12/27/2021 | $22.00 → $6.50 | Overweight → Equal-Weight | Barclays |
| 12/23/2021 | $14.00 → $4.00 | Overweight → Neutral | Piper Sandler |
| 12/17/2021 | $10.00 | Neutral | JP Morgan |
DENVER, May 20, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), welcomes John Koehn as its Senior Vice President of External Affairs as of May 13, 2024. John brings a wealth of experience in healthcare management and a proven track record of success in areas critical to InnovAge's mission and growth, including P&L and risk management, long-term care, provider relations, and business development. John has had exceptional success in fostering close relationships with key stakeholders to drive program manageme
DENVER, Aug. 14, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the appointment of Teresa Sparks to its Board of Directors, effective immediately. Sparks joins InnovAge's Board as Sean Traynor of Welsh, Carson, Anderson & Stowe steps down. The InnovAge team and Board thank Mr. Traynor for his service. "Teresa's diverse experience across multiple sectors, including in financial services, life sciences, specialty pharmacy, healthcare services, and technology, is a huge asset and co
DENVER, March 30, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the appointment of Patty Fontneau to its Board of Directors, effective immediately. Fontneau joins InnovAge's Board as Pavithra Mahesh of Apax Partners and Caroline Dechert of Welsh, Carson, Anderson & Stowe simultaneously step down from their positions with the Board. These changes maintain the participation of the investment firms while adding additional independent and community representation on the Board. The Inno
DEFA14A - InnovAge Holding Corp. (0001834376) (Filer)
DEF 14A - InnovAge Holding Corp. (0001834376) (Filer)
PRE 14A - InnovAge Holding Corp. (0001834376) (Filer)
InnovAge Holding (NASDAQ:INNV) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $193.073 million which beat the analyst consensus estimate of $188.246 million by 2.56 percent. This is a 11.90 percent increase over sales of $172.539 million the same period last year.
Gainers GeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings came out today. InnovAge Holding (NASDAQ:INNV) shares increased by 7.25% to $3.99. The market value of their outstanding shares is at $542.2 million. Mustang Bio (NASDAQ:MBIO) shares increased by 5.48% to $0.25. The market value of their outstanding shares is at $2.5 million. Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 5.23% to $0.79. The market value of their outstanding shares is at $38.1 million. Seelos Therapeutics (NASDAQ:SEEL) shares increased by 4.88% to $0.29. The market
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2025 fiscal first quarter financial results on Tuesday, November 5, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be available via webca
DENVER, Oct. 11, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), a leading Program of All-inclusive Care for the Elderly (PACE) provider, plans to highlight its ongoing clinical, operational, and business transformations at the 2024 National PACE Association (NPA) Conference. As the nation's largest provider of PACE by number of participants, InnovAge provides coordinated and integrated care across a range of physical, medical, and social services. This ensures eligible seniors can age safely in their own homes while maintaining their independence and quality of life. Under President and CEO Patrick Blair, the company has innovated across the business to impr
DENVER, Sept. 26, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (NASDAQ:INNV) (the "Company" or "InnovAge") announced today that its Board of Directors has increased the amount of its common stock that may be repurchased under its share repurchase program (the "Program"), originally approved in June 2024. The increase authorizes the Company to repurchase up to an additional $2.5 million of its common stock, in addition to the $5.0 million originally authorized. Since June 2024, the Company has repurchased a total of 837,372 shares of common stock under the June 2024 authorization, with an aggregate market value of $5.0 million. Share repurchases under the Program may be made from time
4 - InnovAge Holding Corp. (0001834376) (Issuer)
4 - InnovAge Holding Corp. (0001834376) (Issuer)
4 - InnovAge Holding Corp. (0001834376) (Issuer)
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2025 fiscal first quarter financial results on Tuesday, November 5, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be available via webca
DENVER, Aug. 27, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2024 fiscal fourth quarter and full year financial results on Tuesday, September 10, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be avai
DENVER, April 23, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2024 fiscal third quarter financial results on Tuesday, May 7, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be available via webcast for
KeyBanc Capital Markets initiated coverage of InnovAge with a rating of Sector Weight
Robert W. Baird downgraded InnovAge from Outperform to Neutral and set a new price target of $5.00 from $6.00 previously
Piper Sandler downgraded InnovAge from Neutral to Underweight and set a new price target of $5.00 from $4.00 previously